EUVIMEDEUVIMED entdecken
Crossref

Radioligand therapy with lutetium-177-PSMA in metastatic castration-resistant prostate cancer with bone involvement: a comprehensive review

Khakimov G.A. Khakimov, Nasirkhodzhaev Ya.B. Nasirkhodzhaev, Khakimova G.G. Khakimova, Sobitov S.A. Sobitov, Erkinova Sh.I. Erkinova

Pharmateca · 13.07.2026 · 4_2026 · 216-221

DOI: 10.18565/pharmateca.2026.4.216-221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmateca, erschienen am 13.07.2026. Verfasst von Khakimov G.A. Khakimov und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Khakimov, K. G., Nasirkhodzhaev, N. Y., Khakimova, K. G., Sobitov, S. S., & Erkinova, E. S. (2026). Radioligand therapy with lutetium-177-PSMA in metastatic castration-resistant prostate cancer with bone involvement: a comprehensive review. Pharmateca, 4_2026, 216-221. https://doi.org/10.18565/pharmateca.2026.4.216-221

Vancouver

Khakimov KG, Nasirkhodzhaev NY, Khakimova KG, Sobitov SS, Erkinova ES. Radioligand therapy with lutetium-177-PSMA in metastatic castration-resistant prostate cancer with bone involvement: a comprehensive review. Pharmateca. 2026;4_2026:216-221. doi:10.18565/pharmateca.2026.4.216-221

BibTeX
@article{Khakimov2026,
  author = {Khakimov, Khakimov G.A. and Nasirkhodzhaev, Nasirkhodzhaev Ya.B. and Khakimova, Khakimova G.G. and Sobitov, Sobitov S.A. and Erkinova, Erkinova Sh.I.},
  title = {Radioligand therapy with lutetium-177-PSMA in metastatic castration-resistant prostate cancer with bone involvement: a comprehensive review},
  journal = {Pharmateca},
  year = {2026},
  volume = {4_2026},
  pages = {216--221},
  doi = {10.18565/pharmateca.2026.4.216-221}
}
Kostenlos starten →